NCT05155995View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

November 27, 2022

Study Completion Date

November 27, 2022

Conditions
Healthy
Interventions
DRUG

HCP2001

Take it once per period.

DRUG

RLD2007

Take it once per period.

DRUG

RLD2008

Take it once per period.

DRUG

RLD2102

Take it once per period.

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT05155995 - A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers | Biotech Hunter | Biotech Hunter